| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/25/2002 | US20020048777 Nucleotide sequences for use in therapy, monitoring and screning preferential tumors |
| 04/25/2002 | US20020048606 Method of preparing microparticles of one or more phytosterols, phytostanols or mixtures of both |
| 04/25/2002 | US20020048602 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 04/25/2002 | US20020048601 Suppository and composition comprising at least one polyethylene glycol |
| 04/25/2002 | US20020048600 Residual drug content in the device is minimized by the utilization of a flow-promoting layer between a semi-permeable wall; delivery devices having high drug loading |
| 04/25/2002 | US20020048598 Branched polymeric structure which provides a structural support for a mono-layer, bi-layer or multi-layered lipid coating. |
| 04/25/2002 | US20020048597 Reducing the feel of tackiness; increasing stability of oil in water emulsions |
| 04/25/2002 | US20020048576 Enzyme that cleaves a linkage that effects release of a cell-surface protein or carbohydrate and a physiologically acceptable carrier for said enzyme; form suitable for oral administration. |
| 04/25/2002 | US20020048571 Chimeric polypeptides of serum albumin and uses related thereto |
| 04/25/2002 | US20020048570 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048569 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048568 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 04/25/2002 | US20020048567 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048558 Topical delivery systems for active agents |
| 04/25/2002 | US20020048550 Radiolabeled immunotoxins |
| 04/25/2002 | US20020047058 At least one composition of media bodies provides fragments of milling media bodies that are retained with the milled solid substrate particles in the form of a synergetic commixture produced in the milling process. |
| 04/25/2002 | DE10034673C1 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung Dermal application system for aminolevulinic acid and its use |
| 04/25/2002 | CA2689856A1 Composition and method for stable injectable liquids |
| 04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | CA2426697A1 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 04/25/2002 | CA2425831A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
| 04/25/2002 | CA2425605A1 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | CA2425221A1 Protein c or activated protein c-like molecules |
| 04/25/2002 | CA2424345A1 Liposomal formulation of mitoxantrone |
| 04/25/2002 | CA2423843A1 Uses of monoclonal antibody 8h9 |
| 04/25/2002 | CA2423469A1 Methods and products related to pulmonary delivery of polysaccharides |
| 04/25/2002 | CA2422639A1 Acylated cellobiose compounds |
| 04/24/2002 | EP1199566A1 Methods of screening affinity marker libraries |
| 04/24/2002 | EP1199079A2 Use of plant extract for treatment and prevention of sore throats |
| 04/24/2002 | EP1199077A1 Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers |
| 04/24/2002 | EP1198995A1 Anti-stress composition for incorporation in nutritional carriers |
| 04/24/2002 | EP1198589A1 Tenascin-c nucleic acid ligands |
| 04/24/2002 | EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/24/2002 | EP1198570A1 Monomeric protein of the tgf-beta family |
| 04/24/2002 | EP1198508A1 Preparations containing no cross-linking agents |
| 04/24/2002 | EP1198494A1 Preparations that are devoid of cross-linking agents |
| 04/24/2002 | EP1198490A1 Neutral lipopolymer and liposomal compositions containing same |
| 04/24/2002 | EP1198489A1 Combinations for introducing nucleic acids into cells |
| 04/24/2002 | EP1198488A1 Biodegradable block copolymers with modifiable surface |
| 04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 04/24/2002 | EP1198254A2 Carrier-drug conjugate |
| 04/24/2002 | EP1198253A2 Biologically active materials |
| 04/24/2002 | EP1198228A2 Release of poorly soluble agents |
| 04/24/2002 | EP1198226A1 Mesalazine controlled release oral pharmaceutical compositions |
| 04/24/2002 | EP1198223A2 Ophthalmic composition comprising ketotifen |
| 04/24/2002 | EP1156787A4 Oxadiazole compounds and compositions for delivering active agents |
| 04/24/2002 | EP0904066A4 Prodrug compositions and drug delivery methods using synthetic receptors |
| 04/24/2002 | EP0853494B1 Oil-water emulsifiers |
| 04/24/2002 | EP0851768B1 Interactive molecular conjugates |
| 04/24/2002 | EP0841854B1 Compositions for embolizing blood vessels |
| 04/24/2002 | EP0820299B1 Formulations for il-12 |
| 04/24/2002 | EP0797452B1 Modulating the immune response |
| 04/24/2002 | EP0743860B1 Preparation of hollow microcapsules |
| 04/24/2002 | EP0621877B2 Esters of pectic and pectinic acid |
| 04/24/2002 | CN1346369A Method and compositions for the prevention and treatment of anamia |
| 04/24/2002 | CN1346366A Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 04/24/2002 | CN1346283A External coated chewing gum products |
| 04/24/2002 | CN1346279A Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 04/24/2002 | CN1346276A Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
| 04/24/2002 | CN1346274A Formulation comprising testosteron undecanoate and castor oil |
| 04/24/2002 | CN1346273A Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/24/2002 | CN1346270A Compositions having improved stability |
| 04/24/2002 | CN1346265A Preparations for percutaneous absorption |
| 04/24/2002 | CN1346262A Antimicrobial wipes which provide improved immediate germ reduction |
| 04/24/2002 | CN1346252A Prolonged release bioadhesive vaginal gel dosage form |
| 04/24/2002 | CN1083459C Process for preparing polymer powders redispersible in aqueous solution and prepared polymer powders |
| 04/24/2002 | CN1083455C photocurable glycosminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof |
| 04/24/2002 | CN1083280C Novel targeted compositions for diagnostic and therapeutic use |
| 04/24/2002 | CN1083279C Gel form of a vaccine and preparation process thereof |
| 04/24/2002 | CN1083265C Improved pharmaceutical formulations containing ibuprofen and codeine |
| 04/24/2002 | CN1083262C Composition of L-dopa esters |
| 04/24/2002 | CN1083260C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
| 04/23/2002 | US6376669 Dye labeled imidazoquinoline compounds |
| 04/23/2002 | US6376617 Antitumor agents |
| 04/23/2002 | US6376604 Method for the preparation of 1-benzotriazolylcarbonate esters of poly(ethylene glycol) |
| 04/23/2002 | US6376545 Tablet |
| 04/23/2002 | US6376481 Solid oral dosage form comprising support having given surface area range such as silicon dioxide, a stanol ester to reduce cholesterol, and a mixed micelle surfactant system |
| 04/23/2002 | US6376470 Cytosine arabinose, cytarabine, 1-(beta-d-arabinofuranosyl) cytosine nucleotide analog anticancer for acute myelogenous leukemia and some non-solid tumors; ara-c residues are only found on the termini of the polyethylene glycol polymer |
| 04/23/2002 | US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders |
| 04/23/2002 | US6376460 Method of modulating cellular activity |
| 04/23/2002 | US6376248 Peptide-enhanced transfections |
| 04/23/2002 | US6376242 Reduce the number of circulating platelets to low or below normal levels. |
| 04/23/2002 | US6376219 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems |
| 04/23/2002 | US6376217 Fusion protein comprising gelonin amino acid sequence having enzymatic activity and antibody, antigen-binding fragment, hormone, lymphokine or growth factor targeting sequence allowing internalization of fusion protein |
| 04/23/2002 | US6375988 Drug composition with controlled drug release rate |
| 04/23/2002 | US6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
| 04/23/2002 | US6375984 Aqueous-based pharmaceutical composition |
| 04/23/2002 | US6375983 Microencapsulated fragrances and method for preparation |
| 04/23/2002 | US6375978 Pre-annealing membrane polymer |
| 04/23/2002 | US6375975 Pharmaceutical compositions for buccal and pulmonary application |
| 04/23/2002 | US6375973 Olopatadine and emedastine and an ophthalmically acceptable polymeric quaternary ammonium compound as a preservative |
| 04/23/2002 | US6375970 Administering hydrogel and polymerizing it |
| 04/23/2002 | US6375968 Encapsulated active material immobilized in hydrogel microbeads |
| 04/23/2002 | US6375960 Nanoemulsion based on ethoxylated fatty ethers or on ethoxylated fatty esters and its uses in the cosmetics, dermatological and/or ophthalmological fields |
| 04/23/2002 | US6375951 Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry |
| 04/23/2002 | US6375930 Paramagnetism, photosensitivity; imaging, diagnosis, drug delivery |
| 04/23/2002 | US6375927 Methods of radiotherapy using biomodulators |
| 04/23/2002 | US6375634 Apparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapy |
| 04/23/2002 | CA2268175C Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/2002 | CA2252772C Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents |